
Humacyte, Inc.
Humacyte, Inc.(HUMA)内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签;可在本季度与近12个月之间切换;下方为季度图与交易明细。
SEC EDGAR · FMP · HUMA · 截至 2026年6月8日
活动摘要
买入笔数
8
P-Purchase only
卖出笔数
8
近12个月
买卖比
1.00
Buy/Sell (by trades)
整体情绪
Humacyte, Inc.内部人在过去近12个月买卖活动混合。
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
HUMA 季度内部人买卖趋势
HUMA 内幕交易卖出 · HUMA 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · HUMA CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
HUMA 高管卖出股份 · HUMA 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 19, 2026 | Sebelius Kathleen Director | Purchase | 56,818 | $50K | Form 4 |
| May 18, 2026 | Constantino Michael T. Director | Purchase | 11,000 | $10K | Form 4 |
| May 18, 2026 | Sander Dale A. CFO and Chief Corp. Dev. Off | Sale | 45,887 | $41K | Form 4 |
| May 18, 2026 | Parikh Shamik J Chief Medical Officer | Sale | 45,887 | $41K | Form 4 |
| Nov 16, 2025 | Sander Dale A. CFO and Chief Corp. Deve. Off. | Award | 311,100 | — | Form 4 |
| Nov 16, 2025 | Parikh Shamik J Chief Medical Officer | Award | 311,100 | — | Form 4 |
| Aug 18, 2025 | Dougan Brady W Director | Sale | 549,360 | $1.01M⚡ | Form 4 |
| Aug 19, 2025 | Dougan Brady W Director | Sale | 1,100,000 | $1.79M⚡ | Form 4 |
| Aug 20, 2025 | Dougan Brady W Director | Sale | 591,685 | $935K | Form 4 |
| Aug 18, 2025 | Niklason Laura E President, CEO and Director | Sale | 549,360 | $1.01M⚡ | Form 4 |
| Aug 19, 2025 | Niklason Laura E President, CEO and Director | Sale | 1,100,000 | $1.79M⚡ | Form 4 |
| Aug 20, 2025 | Niklason Laura E President, CEO and Director | Sale | 591,685 | $935K | Form 4 |
| Apr 14, 2025 | Scheessele William John Chief Commercial Officer | Purchase | 6,493 | $10K | Form 4 |
| Apr 10, 2025 | Sander Dale A. CFO and Chief Corp. Deve. Off. | Purchase | 20,000 | $31K | Form 4 |
| Apr 10, 2025 | Parikh Shamik J Chief Medical Officer | Purchase | 7,500 | $12K | Form 4 |
| Apr 8, 2025 | Sebelius Kathleen Director | Purchase | 50,000 | $66K | Form 4 |
| Apr 8, 2025 | Green Charles Bruce Director | Purchase | 6,000 | $8K | Form 4 |
| Apr 7, 2025 | Constantino Michael T. Director | Purchase | 16,000 | $20K | Form 4 |
| Dec 4, 2024 | Constantino Michael T. Director | Purchase | 4,600 | $20K | Form 4 |
| Nov 19, 2024 | Niklason Laura E President, CEO and Director | Purchase | 1,797 | $8K | Form 4 |
| Nov 19, 2024 | Dougan Brady W Director | Purchase | 1,797 | $8K | Form 4 |
| Nov 18, 2024 | Niklason Laura E President, CEO and Director | Sale | 811,172 | $3.60M⚡ | Form 4 |
| Nov 19, 2024 | Niklason Laura E President, CEO and Director | Sale | 427,459 | $1.86M⚡ | Form 4 |
| Nov 20, 2024 | Niklason Laura E President, CEO and Director | Sale | 261,369 | $1.15M⚡ | Form 4 |
| Nov 18, 2024 | Dougan Brady W Director | Sale | 811,172 | $3.60M⚡ | Form 4 |
Niklason Laura E
President, CEO and Director
日期
Aug 18
股数
549,360
均价
$1.83
总金额
$1.01M ⚡
Niklason Laura E
President, CEO and Director
日期
Aug 19
股数
1,100,000
均价
$1.63
总金额
$1.79M ⚡
Niklason Laura E
President, CEO and Director
日期
Aug 20
股数
591,685
均价
$1.58
总金额
$935K
Scheessele William John
Chief Commercial Officer
日期
Apr 14
股数
6,493
均价
$1.54
总金额
$10K
Sander Dale A.
CFO and Chief Corp. Deve. Off.
日期
Apr 10
股数
20,000
均价
$1.53
总金额
$31K
Niklason Laura E
President, CEO and Director
日期
Nov 19
股数
1,797
均价
$4.44
总金额
$8K
Niklason Laura E
President, CEO and Director
日期
Nov 18
股数
811,172
均价
$4.44
总金额
$3.60M ⚡
Niklason Laura E
President, CEO and Director
日期
Nov 19
股数
427,459
均价
$4.34
总金额
$1.86M ⚡
Niklason Laura E
President, CEO and Director
日期
Nov 20
股数
261,369
均价
$4.40
总金额
$1.15M ⚡
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源:SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 HUMA 内幕交易
HUMA 内幕交易
Humacyte, Inc.(HUMA)内幕交易数据来源于公司内部人(包括Dougan Brady W (Director), Niklason Laura E (President, CEO and Director), Sander Dale A. (CFO and Chief Corp. Dev. Off))提交的SEC Form 4申报文件。过去12个月内,5位内部人向SEC提交了交易申报。HUMA内部人近期买卖活动混合,这可能反映预设的10b5-1计划执行,而非方向性判断。
如需查看Humacyte, Inc.机构持仓比例和内部人持股百分比,请访问持仓(Ownership)标签页 → Ownership tab →
常见问题
HUMA 内幕交易 · 5个问题Humacyte, Inc.(HUMA)的内部人包括高管和董事,如Dougan Brady W (Director), Niklason Laura E (President, CEO and Director), Sander Dale A. (CFO and Chief Corp. Dev. Off)等。过去12个月内,5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源:FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026